Boston Scientific: Ekos Endovascular System Superior to Standard of Care

 Boston Scientific announced positive results from the global HI-PEITHO randomized clinical trial, which found that the EKOS Endovascular System plus anticoagulation was superior to the current standard of care - anticoagulation alone - for the treatment of acute pulmonary embolism (PE). The trial met its composite primary endpoint, showing a 61% reduction in PE-related mortality, non-fatal hemodynamic cardiorespiratory decompensation or collapse, and non-fatal symptomatic recurrence of PE within seven days.

https://nationaltoday.com/us/ma/marlborough/news/2026/03/28/boston-scientifics-ekos-system-outperforms-standard-of-care-for-acute-pulmonary-embolism/